Sandusky, OH, Feb. 03, 2022 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company expects to enjoy increased market visibility for its RX Branded CBD Nutraceuticals resulting from the kickoff of the USMJ Ecommerce expansion campaign announced earlier today.
Sandusky, OH, Feb. 01, 2022 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today republished its 2022 strategic update on the company’s CBD pharmaceutical and nutraceutical development strategy. The update was originally released on Friday, January 27th, 2022.
Sandusky, OH, Jan. 28, 2022 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today released a 2022 strategic update on the company’s CBD pharmaceutical and nutraceutical development strategy.
SANDUSKY, Ohio, Nov. 10, 2021 /PRNewswire/ -- PAO Group, Inc. (USOTC: PAOG) and Puration, Inc. (USOTC: PURA) today announced the companies will partner on the development of a line of CBD products for Women's Health.
SANDUSKY, Ohio, Oct. 20, 2021 /PRNewswire/ -- PAO Group, Inc. (USOTC: PAOG) today revealed the company has been working on the development of CBD products for pets and could have its first product ready to introduce before the end of the year.
Sandusky, OH, Oct. 18, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) earlier today announced the launch of its first CBD nutraceutical product, RelaxRX CBD, a sleep aid.
SANDUSKY, Ohio, Oct. 14, 2021 /PRNewswire/ -- PAO Group, Inc. (USOTC: PAOG) today announced encountering a flurry of outside interest of late into the company's CBD pharmaceutical respiratory treatment research.
Sandusky, OH, Oct. 11, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company expects to realize its first CBD nutraceutical product sales beginning imminently in Q4, 2021.
SANDUSKY, Ohio, Oct. 8, 2021 /PRNewswire/ -- PAO Group, Inc. (USOTC: PAOG) today announced shipping its first CBD nutraceutical product to its distribution partner, North American Cannabis Holdings, Inc. (USOTC: USMJ).